![](/img/cover-not-exists.png)
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib
Fiala, Ondrej, Pesek, Milos, Finek, Jindrich, Topolcan, Ondrej, Racek, Jaroslav, Minarik, Marek, Benesova, Lucie, Bortlicek, Zbynek, Poprach, Alexandr, Buchler, TomasVolume:
36
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-015-3660-3
Date:
December, 2015
File:
PDF, 441 KB
english, 2015